Part 6/13:

Both Indonesia and the Philippines have undertaken multiple strategies to combat the crisis, though challenges remain. Indonesia's reliance on Chinese vaccines like Sinovac and collaborations with its own state-owned vaccine producer, PT Biofarma, have been central to its strategy. Indonesia also signed deals with Western pharmaceutical giants such as AstraZeneca and sought to manufacture vaccines locally, including developing its own candidate, Sinovac-based "Samavax," which showed promising 65% efficacy in trials.